The University of the Sunshine Coast Clinical Trials Centre will soon begin a trial of a potential new treatment for coeliac disease in people who have symptoms despite following a gluten-free diet.

Researchers at the University of the Sunshine Coast are set to trial a medication aimed at protecting immune-compromised people against current Omicron variants of COVID-19.

A clinical trial will test the effectiveness of a new antimalarial drug that could help to combat the mosquito-borne disease in parts of the world where malaria parasites are becoming resistant to current treatments.